臨床試験インフラの地域別分析：中東と北アフリカ

Clinical Trial Infrastructure Regional Analysis Market: Middle East and North Africa

商品番号 : SMB-74665

出版社	BCC Research
出版年月	2025年3月
ページ数	81
価格タイプ	シングルユーザライセンス
価格	USD 2,950
種別	英文調査報告書

Report Highlights

This report provides an overview of the clinical trial infrastructure markets in the Middle East and North Africa (MENA) region. It includes a detailed examination of the market dynamics and an understanding of the MENA clinical trial landscape by study status, phase, type, results and sponsor type.

このレポートでは、中東および北アフリカ (MENA) 地域の臨床試験インフラ市場の概要を説明します。市場動向の詳細な調査と、研究ステータス、フェーズ、タイプ、結果、スポンサータイプ別の MENA 臨床試験の状況の理解が含まれています。

Report Scope

This report analyzes the Middle East and North Africa (MENA) clinical trial markets, using 2023 as a benchmark year, and offers projections for the forecast period from 2024 to 2029, with estimates of compound annual growth rates (CAGR). The report covers many aspects of the market, including clinical advances, economic factors and business considerations, and outlines the market forces impacting the industry and its phases, study types and therapeutic areas. The report segments the clinical trial market into services, solutions and supplies, and examines the regional dynamics influencing the market.

This report excluded Turkey and Israel from its scope because their clinical trial markets are significantly more advanced than other countries in the MENA region. Including these markets would have skewed the analysis and not accurately reflected the opportunities and challenges the rest of the region faces. This approach ensures a focused examination of MENA’s emerging clinical trial landscape, which may be more relevant for companies seeking to expand into less mature markets.

Report Synopsis

Report Metrics	Details
Base year considered	2023
Forecast period considered	2024-2029
Base year market size	$896.4 Million
Market size forecast	$1.3 Billion
Growth rate	CAGR of 6.2% from 2024 to 2029
Units considered	$ Millions
Segments covered	By Sponsor Type, Clinical Trial Phase, Service Type, Study Type, Therapeutic Area, and Country
Countries covered	Egypt, Saudi Arabia, Lebanon, UAE and Iran
Key Market Drivers	Regulatory frameworks driving trial feasibility. Growing patient population, enhancing recruitment and diversity. Technological advances streamlining operations. Collaborations driving growth and innovation. Personalized medicine shaping trial design.

Report Includes

– Analysis of the Middle East and Northern Africa’s (MENA) regional markets for clinical trial infrastructure

– Analyses of the market trends, with revenue data for 2023, estimates for 2024, and projected CAGRs through 2029

– Estimate of the current market size and revenue prospects, accompanied by a market share analysis by sponsor type, clinical trial phase, service type, study type, therapeutic area, and country

– An understanding of the opportunities and progressions in clinical trial studies by some select countries in emerging MENA markets

– Facts and figures pertaining to the current market dynamics, advancements in technology, regulations and prospects

– Insights of the ripple effects of the Ukraine-Russia war on clinical trial operations, including supply chain disruptions, regulatory challenges, and patient recruitment and retention

– Analysis of the industry structure, including stakeholders’ market shares, clinical trial product/services mapping, and recent key developments

Chapter 1 Executive Summary

Market Outlook

Scope of Report

Reasons for Doing this Study

Market Summary

Chapter 2 MENA Clinical Trial Industry Outlook

Global Clinical Trial Market Overview

MENA Share

Evolving MENA Clinical Trial Industry

Infrastructure and Resources: Bridging Gaps in Emerging Markets

Patient Recruitment Potential: Diverse Populations and High Recruitment Rates

Cost-Effectiveness

Regulatory Environment: Harmonization and Local Adaptations

Government Support and Investments

Impact of Regional Policies: Incentivizing Clinical Research

Collaborations Expand Regional Networks

Emerging Trends: Focus on Precision Medicine and Rare Diseases

Growing Demand in Oncology and Rare Diseases

Technological Advances: Digitalizing Clinical Operations

Understanding the MENA Clinical Trial Landscape

Chapter 3 Market Dynamics

Market Dynamics

Market Drivers

Regulatory Frameworks Driving Trial Feasibility

Growing Patient Population Enhancing Recruitment and Diversity

Technological Advances Streamlining Operations

Collaborations

Personalized Medicine Shaping Trial Design

Market Challenges

Complex Regulatory Landscape

Limited Patient Recruitment and Retention

Insufficient Infrastructure and Site Capacity

Limited Adoption of Digital Technologies

Competition for Key Therapeutic Areas

Market Opportunities

Regulatory Reforms Enabling Faster Approvals

Emerging Focus on Oncology and Rare Diseases

Public-Private Partnerships Boosting Research Capacity

Focus on Precision Medicine and Genomics

Chapter 4 Market Segmentation Analysis

Segmentation Breakdown

Market Analysis, by Sponsor Type

Market Analysis, by Phase

Market Analysis, by Service Type

Market Analysis, by Study Type

Market Analysis, by Therapeutic Area

Chapter 5 Emerging Markets

Egypt

Overview